An inexorable switch from antibiotics has become a major desideratum to overcome antibiotic resistance. Bacteriocin from , a cardinal probiotic was used to design novel antibacterial peptides named as Probiotic Bacteriocin Derived and Modified (PBDM) peptides (PBDM1: YKWFAHLIKGLC and PBDM2: YKWFRHLIKKLC). The loop-shaped 3D structure of peptides was characterized via molecular dynamics simulation as well as biophysically via spectroscopic methods. Thereafter, results against multidrug resistant bacterial strains and hospital samples demonstrated the strong antimicrobial activity of PBDM peptides. Further, studies with PBDM peptides showed downright recovery of balb/c mice from Vancomycin Resistant (VRSA) infection to its healthy condition. Thereafter, study with human epithelial cells showed no significant cytotoxic effects with high biocompatibility and good hemocompatibility. In conclusion, PBDM peptides displayed significant antibacterial activity against certain drug resistant bacteria which cause infections in human beings. Future analysis are required to unveil its mechanism of action in order to execute it as an alternative to antibiotics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477325 | PMC |
| http://dx.doi.org/10.3389/fmicb.2020.01963 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization and Analysis of Probiotic-Derived Peptides Against Multi Drug Resistance Bacterial Infections.
Front Microbiol
August 2020
Department of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia.
An inexorable switch from antibiotics has become a major desideratum to overcome antibiotic resistance. Bacteriocin from , a cardinal probiotic was used to design novel antibacterial peptides named as Probiotic Bacteriocin Derived and Modified (PBDM) peptides (PBDM1: YKWFAHLIKGLC and PBDM2: YKWFRHLIKKLC). The loop-shaped 3D structure of peptides was characterized via molecular dynamics simulation as well as biophysically via spectroscopic methods.
View Article and Find Full Text PDFParacrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages.
Cells
February 2020
IRCCS Regina Elena National Cancer Institute, Oncogenomic and Epigenetic Unit, Via E. Chianesi, 53, 00144 Rome, Italy.
Background: Tumor-associated macrophages (TAMs) constitute a major portion of the leukocyte infiltrate found in breast cancer (BC). BC cells may reprogram TAMs in a pro-angiogenic and immunosuppressive sense. We previously showed that high expression of the ID4 protein in triple-negative BC cells leads to the induction of a proangiogenic program in TAMs also through the downregulation of miR-107.
View Article and Find Full Text PDFPre-eclampsia affects procalcitonin production in placental tissue.
Am J Reprod Immunol
April 2018
Department of Life Sciences, University of Trieste, Trieste, Italy.
Problem: Procalcitonin (PCT) is the prohormone of calcitonin which is usually released from neuroendocrine cells of the thyroid gland (parafollicular) and the lungs (K cells). PCT is synthesized by almost all cell types and tissues, including monocytes and parenchymal tissue, upon LPS stimulation. To date, there is no evidence for PCT expression in the placenta both in physiological and pathological conditions.
View Article and Find Full Text PDFDivergent effects of infliximab and anakinra therapies on macrophage phenotype from patients with refractory rheumatoid arthritis.
Int J Immunopathol Pharmacol
August 2010
Division of BioMedical Sciences, Faculty of Medicine, Memorial University, St John's, Newfoundland, Canada.
Previously, we documented the co-expression of the inducible nitric oxide synthase (NOS2) and protein kinase C-eta (PKC-eta) in peripheral blood-derived macrophages (PBDM) from moderate to severe rheumatoid arthritis (RA) patients with elevated plasma nitric oxide levels but not from those with non-inflammatory osteoarthritis (OA) or normal plasma NO levels. The presence of PKC-eta was found to be required before macrophages could acquire the NOS2-positive phenotype and make copious levels of NO. In the current study, we report the divergent effects of two biological-based RA therapies which target TNFalpha function (infliximab) or IL1 response (anakinra) on the development of the NOS2-positive phenotype by PBDM in patients with refractory RA.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!